Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.4171
-7.06 %
$ 12.5 M
Market Cap
-0.27
P/E
PRPH - INTEREST INCOME & EXPENSE
Interest Income & Expense PRPH - ProPhase Labs, Inc.
1.28 M
LAST VALUE
5.39%
2 YEAR CAGR
0.00%
5 YEAR CAGR
58.18%
10 YEAR CAGR